Nu-Med Plus, Inc. (NUMD) stock
NUMDOTCGold and Silver OresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Nu-Med Plus r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2013 it was $66.21K, up 199.2% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $66.21K | +199.2% |
| FY2012 | Dec 31, 2012 | $22.13K | – |
See a number that looks wrong?